Determination of the Proteomic Response to Lapatinib Treatment using a Comprehensive and Reproducible Ion-Current-Based Proteomics Strategy

Journal Title: Journal of Proteomics and Genomics Research - Year 2014, Vol 1, Issue 3

Abstract

Lapatinib, a small molecule tyrosine kinase inhibitor is currently used in the treatment of HER2-positive breast cancer. The aim of this study was to further understanding of lapatinib response for the development of novel treatment lapatinib-focussed treatment strategies. HER2-overexpressing SKBR3 breast cancer cells were treated with lapatinib for 12 hours and the resultant proteome analyzed by a comprehensive ion-current-based LC-MS strategy. Among the 1224 unique protein identified from SKBR3 cell lysates, 67 showed a significant change in protein abundance in response to lapatinib. Of these, CENPE a centromeric protein with increased abundance, was chosen for further validation. Knockdown and inhibition of CENPE demonstrated that CENPE enhances SKBR3 cell survival in the presence of lapatinib. Based on this study, CENPE inhibitors may warrant further investigation for use in combination with lapatinib.

Authors and Affiliations

Kathleen O’Connell, Jun Li, Frank Engler, Kim Hennessy, Fiona O’Neill, Robert M. Straubinger

Keywords

Related Articles

The NH2-Terminal Ig Domains of Insect Projectin could serve as Elastic Elements

The connecting C-filaments of insect indirect flight muscles have been proposed as one of the elements providing muscle elasticity for the asynchronous muscle physiology of derived insects. Two large modular proteins, ke...

Quantitative Proteomics Using 15N SILAC Mouse

In biomedical research the use of mammalian tissues is crucial to increase our understanding of complex human diseases. Mass spectrometry-based proteomic approach has become the most powerful tool of studying large-scale...

Mechanisms Associated with Acquisition of Resistance to Butyrate-Induced Apoptosis in Colorectal Cancer Cells Using Gene Expression Analysis

Colorectal cancer is one of the most commonly diagnosed cancers worldwide and its prevalence can be reduced by changes to lifestyle and diet. Fermentation of dietary fibre by the gut microbiota and formation of short cha...

Download PDF file
  • EP ID EP261093
  • DOI 10.14302/issn.2326-0793.jpgr-13-257
  • Views 117
  • Downloads 0

How To Cite

Kathleen O’Connell, Jun Li, Frank Engler, Kim Hennessy, Fiona O’Neill, Robert M. Straubinger (2014). Determination of the Proteomic Response to Lapatinib Treatment using a Comprehensive and Reproducible Ion-Current-Based Proteomics Strategy. Journal of Proteomics and Genomics Research, 1(3), 27-42. https://europub.co.uk/articles/-A-261093